Specific inhibitor of the 20S proteasome chymotrypsin-like activity1. Inhibition of Brg1 proteasomal degradation by aclacinomycin A reverses (0.25 µM in ILU-18 cells ) the removal of Brg1 from promoters of inflammatory genes elucidating the regulatory ro
* VAT and and shipping costs not included. Errors and price changes excepted